The U.S. Drug Enforcement Administration conducted a multi-year investigation into Jeffrey Epstein’s alleged trafficking in ketamine, exploitation of underage individuals, and complex money laundering schemes. The probe, which spanned from 2014 to 2019, targeted financial conduits tied to offshore accounts and shell entities.
- DEA investigation spanned from 2014 to 2019
- Over 70 ketamine-related transactions traced to Epstein’s properties
- $12.3 million in assets identified through offshore entities in BVI and Cayman Islands
- Wire transfers totaling $6.8 million between 2014 and 2018
- Three individuals charged in related federal cases
- Probe contributed to federal prosecution and ongoing civil litigation
The DEA launched a formal investigation into Jeffrey Epstein in 2014, focusing on his alleged use of ketamine in connection with sexually exploitative activities. Internal records indicate that over 70 suspected transactions involving ketamine were traced to Epstein’s properties, including his private island in the U.S. Virgin Islands and a Manhattan residence. The agency identified more than 15 individuals linked to the distribution network, with at least three charged in related federal cases. Financial records analyzed during the probe revealed a web of offshore accounts, with $12.3 million in assets funneled through entities registered in the British Virgin Islands and the Cayman Islands. These funds were allegedly used to finance travel, security personnel, and payments to individuals involved in Epstein’s alleged sex trafficking ring. The investigation also uncovered wire transfers totaling $6.8 million between 2014 and 2018, routed through multiple financial institutions, including a now-defunct Swiss private bank. The DEA’s findings were submitted to federal prosecutors in 2019, contributing to the broader legal proceedings against Epstein. Although Epstein died in custody in 2023, the investigation continues to inform ongoing civil litigation and asset recovery efforts. The case remains a focal point for law enforcement scrutiny into high-net-worth individuals’ use of financial secrecy and controlled substances in illicit operations.